Marker Therapeutics Inc. Common Stock (MRKR)
Stock · NASDAQ · Health Care
$1.05as of 10/16/2026
Price chart
Active signals
MRKR Signal Track Record
How signals performed across all stocks →What MRKR's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 43 | -5.5% | 47% | October 1, 2026 |
| Bollinger Band Breakout | 27 | -6.9% | 33% | August 19, 2026 |
| Bollinger Band Breakdown | 16 | +3.3% | 50% | September 30, 2026 |
| 200-Day Moving Average TouchActive now | 10 | -0.0% | 50% | June 16, 2026 |
| Any 20-session window (baseline) | -3.6% | 44% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About MRKR
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States. The company's multi antigen recognizing (MAR)-T cell therapy technology is based on the selective expansion of non-engineered tumor-specific T cells that recognize tumor-associated antigens and ki…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 5
- Website
- markertherapeutics.com/
Fundamentals
- 1-day range
- $0.88$0.9595
- Market cap
- $18.67M
- P/E (trailing)
- —
- P/E (forward)
- -1.74
- EPS (trailing)
- $-0.90
- Dividend yield
- —
- Beta
- 1.59
- Avg. volume
- 71.0K
- Dividend pay date
- September 16, 2016
How Marker Therapeutics Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 18, 2026 · via SEC EDGAR / Finnhub
Forecasts
3 analyst ratings
Marker Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- MRKRMarker Therapeutics Inc. Common Stock$1.04▲ 13.04%Market cap $18.67MP/E —$0.84$2.46
- NRSNNeuroSense Therapeutics Ltd. Ordinary Shares$3.07▼ 3.15%Market cap $19.00MP/E —$3.05$26.64
- NCELNewcelX Ltd. Ordinary Shares$2.5▼ 12.28%Market cap $17.98MP/E —$1.83$18.4
- HOWLWerewolf Therapeutics Inc. Common Stock$0.98▼ 1.71%Market cap $19.58MP/E —$0.27$2.24
- CTXRCitius Pharmaceuticals Inc. Common Stock$0.46▲ 0.00%Market cap $17.62MP/E —$0.46$2.19
- RKTORocket One Inc. Common Stock$0.507▼ 5.59%Market cap $19.75MP/E —$0.51$2.45
- CELUCelularity Inc. Class A Common Stock$1.25▼ 6.02%Market cap $19.77MP/E —$0.5601$2.55
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MRKR Marker Therapeutics Inc. Common Stock | $18.67M | — | $1.04 | ▲ 13.04% | $0.84$2.46 |
| NRSN NeuroSense Therapeutics Ltd. Ordinary Shares | $19.00M | — | $3.07 | ▼ 3.15% | $3.05$26.64 |
| NCEL NewcelX Ltd. Ordinary Shares | $17.98M | — | $2.5 | ▼ 12.28% | $1.83$18.4 |
| HOWL Werewolf Therapeutics Inc. Common Stock | $19.58M | — | $0.98 | ▼ 1.71% | $0.27$2.24 |
| CTXR Citius Pharmaceuticals Inc. Common Stock | $17.62M | — | $0.46 | ▲ 0.00% | $0.46$2.19 |
| RKTO Rocket One Inc. Common Stock | $19.75M | — | $0.507 | ▼ 5.59% | $0.51$2.45 |
| CELU Celularity Inc. Class A Common Stock | $19.77M | — | $1.25 | ▼ 6.02% | $0.5601$2.55 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Institutional Ownership
March 31, 2026
- Total shares held
- 3.81M
- Total value held
- $4.94M
- Institutional holders
- 33
- Unknown1.63M
- Unknown554.3K
- Unknown389.3K
- Unknown325.4K
- Unknown175.3K
- Unknown160.9K
- Unknown93.1K
- Unknown83.0K
- Unknown63.6K
- Unknown61.0K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Marker Therapeutics appears in Yahoo's October 16 top picks
Yahoo included Marker Therapeutics in its list of notable stocks for October 16. The mention may increase visibility among investors. The stock is currently near its $1.41 support level and has an RSI of 38.5, suggesting modest momentum.
Marker Therapeutics appears in Yahoo's October 16 top picks. Yahoo included Marker Therapeutics in its list of notable stocks for October 16. The mention may increase visibility among investors. The stock is currently near its $1.41 support level and has an RSI of 38.5, suggesting modest momentum.